Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

Gastroenterology

Volumn 117, Issue 3, 1999, Pages 527-535

  Sandborn, W J ^a   Tremaine, W J ^a   Wolf, D C ^a   Targan, S R ^a   Sninsky, C A ^a   Sutherland, L R ^a   Hanauer, S B ^a   McDonald, J W D ^a   Feagan, B G ^a   Fedorak, R N ^a   Isaacs, K L ^a   Pike, M G ^a   Mays, D C ^a   Lipsky, J J ^a   Gordon, S ^a   Kleoudis, C S ^a   Murdock R H , Jr ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE; TIOGUANINE;

ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; COLON CROHN DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; TREATMENT OUTCOME;

EID: 0032874716     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70445-2     Document Type: Article

References (36)

1. JMT Willoughby PJ Kumar J Beckett AM Dawson Controlled trial of azathioprine in Crohn's disease Lancet 2 1971 944 947
2. JL Rosenberg B Levin AJ Wall JB Kirsner A controlled trial of azathioprine in Crohn's disease Dig Dis 20 1975 721 726
3. DP O'Donoghue AM Dawson J Powell-Tuck RL Brown JE Lennard-Jones Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease Lancet 2 1978 955 957
4. DH Present BI Korelitz N Wisch JL Glass DB Sachar BS Pasternack Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study N Engl J Med 302 1980 981 987
5. K Ewe AG Press CC Singe M Stufler B Ueberschaer G Hommel KHMZ Buschenfelde Azathioprine combined with prednisolone or monotherapy with prednisone in active Crohn's disease Gastroenterology 105 1993 367 372
6. S Candy J Wright M Gerber G Adams M Gerig R Goodman A controlled double blind study of azathioprine in the management of Crohn's disease Gut 37 1995 674 678
7. J Markowitz K Grancher F Mandel F Daum the 6MP Collaborative Group 6-Mercaptopurine (6MP) + prednisone therapy for newly diagnosed pediatric Crohn's disease (CD): a prospective, multicenter, placebo-controlled clinical trial (abstr) Gastroenterology 114 1998 A1032
8. DC Pearson GR May GH Fick LR Sutherland Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis Ann Intern Med 122 1995 132 142
9. L Lennard CB Brown M Fox JL Maddocks Azathioprine metabolism in kidney transplant recipients Br J Clin Pharmacol 18 1984 693 700
10. GLC Chan GR Erfmann SA Gruber AJ Matas DM Canafax Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thioguanine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients J Clin Pharmacol 30 1990 358 363
11. L Lennard JS Lilleyman Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia J Clin Oncol 7 1989 1816 1823
12. S Bergan HE Rugstad O Bentdal L Endresen O Stokke Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment Ther Drug Monit 16 1994 13 20
13. WJ Sandborn EC Van Os BJ Zins WJ Tremaine DC Mays JJ Lipsky An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease Gastroenterology 109 1995 1808 1817
14. WR Best JN Becktel JW Singleton Rederived values of the eight co-efficients of the Crohn's disease activity index (CDAI) Gastroenterology 77 1979 843 846
15. RN Weinshilboum SL Sladek Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity Am J Hum Genet 32 1980 651 662
16. JW Singleton SB Hanauer GL Gitnick MA Peppercorn MG Robinson LD Wruble EL Krawitt the Pentasa Crohn's Disease Study Group Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial Gastroenterology 104 1993 1293 1301
17. GR Greenberg BG Feagan F Martin LR Sutherland ABR Thomsen CN Williams LG Nilsson T Persson the Canadian Inflammatory Bowel Disease Study Group Oral budesonide for active Crohn's disease N Engl J Med 331 1994 836 841
18. OO Thomsen A Cortot D Jewell JP Wright T Winter FT Veloso M Vatn T Persson E Pettersson for the International Budesonide-Mesalamine Study Group A comparison of budesonide and mesalamine for active Crohn's disease N Engl J Med 339 1998 370 374
19. S Zimm LJ Ettinger JS Locenberg BA Kamen TJ Vietti J Belasco N Coglinao-Shutta F Balis LE Lavi JM Collins DG Poplack Phase 1 in a clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion Cancer Res 45 1985 1869 1873
20. PC Adamson S Zimm AH Ragab SM Steinberg F Balis BA Kamen TJ Vietti A Gillespie DG Poplack A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors Cancer Chemother Pharmacol 26 1990 343 344
21. BG Feagan J Rochon RN Fedorak EJ Irvine G Wild L Sutherland AH Steinhart GR Greenberg R Gillies M Hopkins SB Hanauer JWD McDonald for the North American Crohn's Disease Study Group investigators Methotrexate for the treatment of Crohn's disease N Engl J Med 332 1995 292 297
22. EJ Irvine B Feagan J Rochon A Archambault RN Fedorak A Groll D Kinnear F Saibil JWD McDonald for the Canadian Crohn's Relapse Prevention Trial Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease Gastroenterology 106 1994 287 296
23. GR Erdmann LA France BC Bostrom DM Canafax A reversed-phase high-performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy Biomed Chromatogr 4 1990 47 51
24. J Rhodes D Bainton P Beck H Campbell Controlled trial of azathioprine in Crohn's disease Lancet 2 1971 1273 1276
25. M Klein HJ Binder M Mitchell R Aaronson H Spiro Treatment of Crohn's disease with azathioprine: a controlled evaluation Gastroenterology 66 1974 916 922
26. RW Summers DN Switz JT Sessions JN Becktel WR Best F Kern JW Singleton National cooperative Crohn's disease study: results of drug treatment Gastroenterology 77 1979 847 869
27. SR Targan SB Hanauer SJH van Deventer L Mayer DH Present TAJ Braakman KL DeWoody TF Schaible P Rutgeerts the Crohn's Disease cA2 Study Group A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease N Engl J Med 337 1997 1029 1035
28. L Lennard JS Lilleyman J Van Loon RN Weinshilboum Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia Lancet 336 1990 225 229
29. AJ Black HL McLeod HA Capell RH Powrie LK Matowe SC Pritchard ESR Collie-Duguid DM Reid Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine Ann Intern Med 129 1998 716 718
30. C Cuffari Y Theoret S Latour G Seidman 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity Gut 39 1996 401 406
31. JS Lilleyman L Lennard Mercaptopurine metabolism and the risk of relapse in childhood lymphoblastic leukaemia Lancet 343 1994 1188 1190
32. DH Present SJ Meltzer MP Krumholz A Wolke BI Korelitz 6-mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity Ann Intern Med 111 1989 641 649
33. WR Connell MA Kamm JK Ritchie JE Lennard-Jones Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years experience Gut 34 1993 1081 1085
34. BS Kirschner Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Gastroenterology 115 1998 813 821
35. L Lennard CA Rees JS Lilleyman JL Maddocks Childhood leukemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia Br J Clin Pharmacol 16 1983 359 363
36. T Colonna BI Korelitz The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease Am J Gastroenterol 89 1994 362 366